KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Novavax (NVAX) Other Gross PP&E Adjustments (2016 - 2024)

Historic Other Gross PP&E Adjustments for Novavax (NVAX) over the last 14 years, with Q4 2024 value amounting to $25.5 million.

  • Novavax's Other Gross PP&E Adjustments fell 8658.7% to $25.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $25.5 million, marking a year-over-year decrease of 8658.7%. This contributed to the annual value of $25.5 million for FY2024, which is 8658.7% down from last year.
  • Per Novavax's latest filing, its Other Gross PP&E Adjustments stood at $25.5 million for Q4 2024, which was down 8658.7% from $189.8 million recorded in Q4 2023.
  • Novavax's 5-year Other Gross PP&E Adjustments high stood at $244.1 million for Q4 2022, and its period low was -$108.7 million during Q3 2022.
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$162500.0 (2021), whereas its average is $37.9 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 376014.76% in 2020, then tumbled by 10247735.85% in 2022.
  • Quarter analysis of 5 years shows Novavax's Other Gross PP&E Adjustments stood at $167.4 million in 2020, then grew by 11.56% to $186.7 million in 2021, then soared by 30.72% to $244.1 million in 2022, then decreased by 22.25% to $189.8 million in 2023, then tumbled by 86.59% to $25.5 million in 2024.
  • Its Other Gross PP&E Adjustments was $25.5 million in Q4 2024, compared to $189.8 million in Q4 2023 and $244.1 million in Q4 2022.